Zimmer Biomet will buy Embody, developer of the Tapestry biointegrative orthopedic repair devices, to fill a gap in its sports medicine portfolio.
"Embody's differentiated products and innovative pipeline in the area of sports medicine support our continued focus on and investment in...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?